Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate- or polyethylene glycol-modified arginine-rich peptide
- 1 September 2017
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 530 (1-2) , 195-200
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (JSPS)
- Nakatomi Foundation
This publication has 18 references indexed in Scilit:
- Quantitative analysis of drug delivery to the brain via nasal routeJournal of Controlled Release, 2014
- Prolongation of Life in Rats with Malignant Glioma by Intranasal siRNA/Drug Codelivery to the Brain with Cell-Penetrating Peptide-Modified MicellesMolecular Pharmaceutics, 2014
- Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micellesBiomaterials, 2013
- Intranasal Treatment of Central Nervous System Dysfunction in HumansPharmaceutical Research, 2012
- Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG–PCL nanomicellesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2012
- Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal AdministrationPharmaceutical Research, 2011
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerationsJournal of Pharmaceutical Sciences, 2010
- Is nose-to-brain transport of drugs in man a reality?Journal of Pharmacy and Pharmacology, 2004
- Transport of Nanoparticles Across the Rat Nasal MucosaJournal of Drug Targeting, 2001
- Transport of drugs from the nasal cavity to the central nervous systemEuropean Journal of Pharmaceutical Sciences, 2000